AGRN immunostaining, specifically targeting the muscularis mucosa, may serve as a novel biomarker for distinguishing SSL, hyperplastic polyps (HP), traditional serrated adenomas (TSA) and tubular adenomas (TA).35 The gene discussed is AGRN; the disease is hyperplastic polyp.